Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dangas

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximabG Dangas, J J Badimon, B S Coller, et al.
The American Journal of Cardiology|July 15, 1997
Risk factors for the development of slow flow during rotational coronary atherectomyS K Sharma, G Dangas, R Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 4, 2001
Acute renal failure requiring dialysis after percutaneous coronary interventionsL Gruberg, R Mehran, G Dangas, et al.
The American Journal of Cardiology|May 10, 2000
Antithrombotic effects of abciximabR Hayes, J H Chesebro, V Fuster, et al.
The American Journal of Cardiology|June 27, 2000
Atrial fibrillation after beating heart surgeryS C Stamou, G Dangas, P C Hill, et al.
Journal of the American College of Cardiology|April 8, 1999
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profileG Dangas, J J Badimon, D A Smith, et al.
Journal of the American College of Cardiology|August 31, 2001
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devicesG Dangas, R Mehran, S Kokolis, et al.
The American Journal of Cardiology|July 29, 2000
In vivo demonstration of an antithrombin effect of abciximabJ A Ambrose, M Hawkey, J J Badimon, et al.
The American Journal of Cardiology|August 24, 2000
Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplastyM K Hong, R Mehran, G Dangas, et al.
Journal of the American College of Cardiology|July 14, 2001
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 resultsM K Hong, R Mehran, G Dangas, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximabG Dangas, J J Badimon, B S Coller, et al.
The American Journal of Cardiology|July 15, 1997
Risk factors for the development of slow flow during rotational coronary atherectomyS K Sharma, G Dangas, R Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 4, 2001
Acute renal failure requiring dialysis after percutaneous coronary interventionsL Gruberg, R Mehran, G Dangas, et al.
The American Journal of Cardiology|May 10, 2000
Antithrombotic effects of abciximabR Hayes, J H Chesebro, V Fuster, et al.
The American Journal of Cardiology|June 27, 2000
Atrial fibrillation after beating heart surgeryS C Stamou, G Dangas, P C Hill, et al.
Journal of the American College of Cardiology|April 8, 1999
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profileG Dangas, J J Badimon, D A Smith, et al.
Journal of the American College of Cardiology|August 31, 2001
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devicesG Dangas, R Mehran, S Kokolis, et al.
The American Journal of Cardiology|July 29, 2000
In vivo demonstration of an antithrombin effect of abciximabJ A Ambrose, M Hawkey, J J Badimon, et al.
The American Journal of Cardiology|August 24, 2000
Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplastyM K Hong, R Mehran, G Dangas, et al.
Journal of the American College of Cardiology|July 14, 2001
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 resultsM K Hong, R Mehran, G Dangas, et al.
Pageof 8